Screener
AnaptysBio, Inc. ANAB Total Revenue
Total Revenue at other companies
Other financials
Where this comes from
Reported directly by AnaptysBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219515
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Collaboration revenue | $25,556 | $27,771 |
| Operating expenses: | ||
| Research and development | 33,991 | 41,180 |
| General and administrative | 26,202 | 14,130 |
| Total operating expenses | 60,193 | 55,310 |
| Loss from operations | (34,637) | (27,539) |
| Other income (expense), net: | ||
| Interest income | 2,653 | 4,413 |
Item 1. Consolidated Financial Statements
FAQ
- What is AnaptysBio, Inc.'s total revenue?
- AnaptysBio, Inc. (ANAB) reported total revenue of $25.56M in Q1 2026.
- How has AnaptysBio, Inc.'s total revenue changed year-over-year?
- AnaptysBio, Inc.'s total revenue decreased by 8.0% year-over-year, from $27.77M to $25.56M.
- What is the long-term trend for AnaptysBio, Inc.'s total revenue?
- Over 4 years (2021 to 2025), AnaptysBio, Inc.'s total revenue has grown at a 38.8% compound annual growth rate (CAGR), from $63.18M to $234.6M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about AnaptysBio, Inc.'s total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude